Pharmacogenomics of human ABC transporters: Detection of clinically important SNPs by SmartAmp2 method

Current Pharmaceutical Biotechnology

Volumn 12, Issue 4, 2011, Pages 693-704

  Aw, Wanping ^a   Ota, Ikuko ^b,c   Toyoda, Yu ^d   Lezhava, Alexander ^a   Sakai, Yasuo ^e   Gomi, Tsuneaki ^f   Hayashizaki, Yoshihide ^a   Ishikawa, Toshihisa ^a  

^a RIKEN YOKOHAMA INSTITUTE   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^d TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^e OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^f Gomi Clinic   (Japan)

Author keywords

ABCC11 (MRP8); ABCC4 (MRP4); Apocrine gland; Breast cancer; Osmidrosis; Thiopurine S methyltransferase (TPMT)

Indexed keywords

ABC TRANSPORTER; BIOLOGICAL MARKER; CYTOCHROME P450 2C19; MULTIDRUG RESISTANCE PROTEIN 1;

ALLELE; DNA ISOLATION; FLUORESCENCE ANALYSIS; GENE AMPLIFICATION; GENE FUNCTION; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HYBRIDIZATION; NUCLEIC ACID ANALYSIS; PHARMACOGENOMICS; POLYMERASE CHAIN REACTION; PROTEIN CLEAVAGE; REVIEW; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMART AMPLIFICATION PROCESS 2;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; DISEASE; HUMANS; MUTATION; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 78751499180     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111795164011     Document Type: Review

References (68)

1. Kalow, W.; Meyer, U.A.; Tyndale, R.F., Eds.; Pharmacogenomics, Marcel Dekker, New York, 2001.
2. Wilke, R.A.; Lin, D.W.; Roden, D.M.; Watkins, P.B.; Flockhart, D.; Zineh, I.; Giacomini, K.M.; Krauss, R.M. Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat. Rev. Drug Discov., 2007, 6, 904-916.
3. Weiss, S.T.; McLeod, H.L.; Flockhart, D.A.; Dolan, M.E.; Benowitz, N.L.; Johnson, J.A.; Ratain, M.J.; Giacomini, K.M. Creating and evaluating genetic tests predictive of drug response. Nat. Rev. Drug Discov., 2008, 7, 568-574.
4. Sadee, W. Drug therapy and personalized health care: pharmacogenomics in perspective. Pharm. Res., 2008, 25(12), 2713-2719.
5. Andersson, T.; Flockhart, D.A.; Goldstein, D.B.; Huang, S.M.; Kroetz, D.L.; Milos, P.M.; Ratain, M.J.; Thummel, K. Drugmetabolizing enzymes: evidence for clinical utility of pharmacogenomic tests. Clin. Pharmacol. Ther., 2005, 78(6), 559-581.
6. Kim, R.B. Pharmacogenetics of CYP enzymes and drug transporters: remarkable recent advances. Adv. Drug Deliv. Rev., 2002, 54(10), 1241-1242.
7. Ishikawa. T.; Tsuji, A.; Inui, K.; Sai, Y.; Anzai, N.; Wada, M.; Endou, H.; Sumino, Y. The genetic polymorphism of drug transporters: functional analysis approaches. Pharmacogenomics, 2004, 5(1), 67-99.
8. Giacomini, K.M.; Huang, S.M.; Tweedie, D.J.; Benet, L.Z.; Brouwer, K.L.; Chu, X.; Dahlin, A.; Evers, R.; Fischer, V.; Hillgren, K.M.; Hoffmaster, K.A.; Ishikawa, T.; Keppler, D.; Kim, R.B.; Lee, C.A.; Niemi, M.; Polli, J.W.; Sugiyama, Y.; Swaan, P.W.; Ware, J.A.; Wright, S.H.; Yee, S.W.; Zamek-Gliszczynski, M.J.; Zhang, L. Membrane transporters in Drug Development: Report from the FDA Critical Path Initiative-Sponsored Workshop. Nat. Rev. Drug Discov., 2010, 9, 215-236.
9. Kroetz, D.L.; Yee, S.W.; Giacomini, G.K. The pharmacogenomics of membrane transporters project: research at the interface of genomics and transporter pharmacology. Clin. Pharmacol. Ther., 2010, 87(1); 109-116.
10. Holland, I.B.; Cole, S. P. C.; Kuchler, K.; Higgins, C.F., Eds., ABC Protein: From Bacteria to Man; Academic Press: Amsterdam, 2002.
11. Borst, P.; Elferink, R.O. Mammalian ABC transporters in health and disease. Annu. Rev. Biochem., 2002, 71, 537-592.
12. Toyoda, Y.; Sakurai, A.; Mitani, Y.; Nakashima, M.; Yoshiura, K.; Nakagawa, H.; Sakai, Y.; Ota, I.; Lezhava, A.; Hayashizaki, Y.; Niikawa, N.; Ishikawa, T. Earwax, osmidrosis, and breast cancer: why does one SNP (538G>A) in the human ABC transporter ABCC11 gene determine earwax type? FASEB J., 2009, 23(6), 2001-2013.
13. Inoue Y, Mori T, Toyoda Y, Sakurai A, Ishikawa T, Mitani Y, Hayashizaki Y, Yoshimura Y, Kurahashi H, Sakai Y. Correlation of axillary osmidrosis to a SNP in the ABCC11 gene determined by the Smart Amplification Process (SmartAmp) method. J. Plast. Reconstr. Aesthet. Surg., 2009, 63(8),1369-1374
14. Woodward, O.M.; Köttgen, A.; Coresh, J.; Boerwinkle, E.; Guggino, W.B.; Köttgen, M. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc. Natl. Acad. Sci. USA, 2009, 106(25), 10338-10342.
15. Matsuo, H.; Takada, T.; Ichida, K.; Nakamura, T.; Nakayama, A.; Ikebuchi, Y. Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci. Transl. Med., 2009, 1: 5ra11.
16. Wang, B.; Miao, Z.; Liu, S.; Wang, J.; Zhou, S.; Han, L.; Meng, D.; Wang, Y.; Li, C.; Ma, X. Genetic analysis of ABCG2 gene C421A polymorphism with gout disease in Chinese Han male population. Hum. Genet., 2010, 127(2), 245-246.
17. Mitani, Y.; Lezhava, A.; Kawai, Y.; Kikuchi, T.; Oguchi-Katayama, A.; Kogo, Y.; Itoh, M.; Miyagi, T.; Takakura, H.; Hoshi, K.; Kato, C.; Arakawa, T.; Shibata, K.; Fukui, K.; Masui, R.; Kuramitsu, S.; Kiyotani, K.; Chalk, A.; Tsunekawa, K.; Murakami, M.; Kamataki, T.; Oka, T.; Shimada, H.; Cizdziel, P.E.; Hayashizaki, Y. Rapid SNP diagnostics using asmmetric isothermal amplification and a new mismatch-suppression technology. Nat. Methods, 2007, 4(3), 257-262.
18. Fan, J.B.; Chen, X.; Halushka, M.K.; Berno, A.; Huang, X.; Ryder, T.; Lipshutz, R.J.; Lockhart, D.J.; Chakravarti, A. Parallel genotyping of human SNPs using generic high-density oligonucleotide tag arrays. Genome Res., 2000, 10, 853-860.
19. Saperstein, D.A.; Nickerson, J.M. Restriction fragment length polymorphism analysis using PCR coupled to restriction digests. Biotechniques, 1991, 10(4), 488-489.
20. Heim, M.; Meyer, U.A. Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification. Lancet, 1990, 336, 529-532.
21. See, D.; Kanazin, V.; Talbert, H.; Blake, T. Electrophoretic detection of single-nucleotide polymorphisms. Biotechniques, 2000, 28, 710-714.
22. Griffin, T.J.; Smith, L.M. Single nucleotide polymorphism analysis by MALDI-TOF mass spectrometry. Trends Biotechnol., 2000, 18, 77-84.
23. Ross, P.; Hall, L.; Smirnov, I.; Haff, L. High level multiplex genotyping by MALDI-TOF mass spectrometry. Nat. Biotechnol., 1998, 16, 1347-1351.
24. Bassler, H.A.; Flood, S.J.; Livak, K.J.; Marmaro, J.; Knorr, R.; Batt, C.A. Use of a fluorogenic probe in a PCR-based assay for the detection of Listeria monocytogenes. Appl. Environ. Microbiol., 1995, 61(10), 3724-3728.
25. Livak, K.J. Allelic discrimination using fluorogenic probes and 5' nuclease assay. Genet. Anal., 1999, 14(5-6), 143-149.
26. Lymichev, V.; Mast, A.L.; Hall, J.G.; Prudent, J.R.; Kaiser, M.W.; Takova, T.; Kwiatkowski, R.W.; Sander, T.J.; de Arruda, M.; Arco, D.A.; Neri, B.P; Brow, M.A. Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Nat. Biotechnol., 1999, 17(3), 292-296.
27. Hüebner, C.; Petermann, I.; Browning, B.L.; Shelling, A.N.; Ferguson, L.R. Triallelic single nucletotide polymorphisms and genotyping error in genetic edidemiology studies: MDR1 (ABCB1) G2677/T/A as an example. Cancer Edidemiol. Biomarkers. Prev., 2007, 16(6), 1185-1192.
28. Ishikawa, T.; Sakurai, A.; Hirano, H.; Lezhava, A.; Sakurai, M.; Hayashizaki, Y. Emerging new technologies in pharmacogenomics: Rapid SNP detection, molecular dynamic simulation, and QSAR analysis methods to validate clinically important genetic variants of human ABC Transporter ABCB1 (P-gp/MDR1). Pharmacol. Ther., 2010, 126(1), 69-81.
29. Weinshilboum, R.M.; Sladek, S.L. Mercaptopurine pharamcogenetics: monogenic inheritance of erythrocyte thioprine methyltransferase activity. Am. J. Hum. Genet., 1980, 32, 651-662.
30. Anstey, A.; Lennard, L.; Mayou, S.C.; Kirby, J.D. Pancytopenia related to azathioprine-an enzyme deficiency caused by a common genetic polymorphism: a review. J. Ry.l Soc. Med., 1992, 85, 752-756.
31. Stolk, J.N.; Boerbooms, A.M.; de Abreu, R.A.; de Koning, D.G.; van Beusekom, H.J.; Muller, W.H.; van de Putte, L.B. Reduced thiopurine methyltransferase activity and development of side effects of azathioprine treatment in patients with rheumatoid arthritis. Arthritis Rheum., 1998, 41(10), 1858-1866.
32. Yates, C.R.; Krynetski, E.Y.; Loennechen, T.; Fessing, M.Y.; Tai, H.L.; Pui, C.H.; Relling, M.V.; Evans, W.E. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann. Intl. Med., 1997, 126, 608-614.
33. Black, A.J.; McLeod, H.L.; Capell, H.A.; Powrie, R.H.; Matowe, L.K.; Pritchard, S.C.; Collie-Duguid, E.S.; Reid, D.M. Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann. Intl. Med., 1998, 129, 716-718.
34. Clunie, G.P.; Lennard, L. Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine. Rheumatology, 2004, 43, 13-18.
35. Schuetz, J.D.; Connelly, M.C.; Sun, D.; Paibir, S.G.; Flynn, P.M.; Srinivas, R.V.; Kumar, A.; Fridland, A. MRP4: a previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nat. Med., 1999, 5, 1048-1051.
36. Rius, M.; Hummel-Eisenbeiss, J.; Hofmann, A.F.; Keppler, D. Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione. Am. J. Physiol.-Gastrointest. Liver Physiol., 2006, 290, G640-G649.
37. Leggas, M.; Adachi, M.; Scheffer, G. L.; Sun, D.; Wielinga, P.; Du, G.; Mercer, K. E.; Zhuang, Y.; Panetta, J.C.; Johnston, B.; Scheper, R.J.; Stewart, C.F.; Schuetz, J.D. Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol. Cell. Biol. 2004, 24, 7612-7621.
38. van Aubel, R.A.; Smeets, P.H.; Peters, J.G.; Bindels, R.J.; Russel, F.G. The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. J. Am. Soc. Nephrol., 2002, 13, 595-603.
39. Lee, K.; Klein-Szanto, A.J.; Kruh, G.D. Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells. J. Natl. Cancer Inst., 2000, 92, 1934-1940.
40. Adachi, M.; Sampath, J.; Lan, L.; Sun, D.; Hargrove, P.; Flatley, R.; Tatum, A.; Edwards, M.Z.; Wezeman, M.; Matherly, L.; Drake, R.; Schuetz, J. Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell killing. J. Biol. Chem., 2002, 277, 38998-39004.
41. Anderson, P.L.; Lamba, J.; Aquilante, C.L.; Schuetz, E.; Fletcher, C.V. Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: a pilot study. J. Acquir. Immune Defic. Syndr., 2006, 42, 441-449.
42. Imaoka, T.; Kusuhara, H.; Adachi, M.; Schuetz, J.D.; Takeuchi, K.; Sugiyama, Y. Functional involvement of multidrug resistanceassociated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir. Mol. Pharmacol., 2007, 71, 619-627.
43. Chen, Z.S.; Lee, K.; Walther, S.; Raftogianis, R.B.; Kuwano, M.; Zeng, H.; Kruh, G.D. Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. Cancer Res., 2002, 62, 3144-3150.
44. Wielinga, P. R.; Reid, G.; Challa, E.E.; Van Der Heijden, I.; Van Deemter, L.; De Haas, M.; Mol, C.; Kuil, A.J.; Groeneveld, E.; Schuetz, J.D.; Brouwer, C.; De Abreu, R.A.; Wijnholds, J.; Beijnen, J.H.; Borst, P. Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells. Mol. Pharmacol., 2002, 62, 1321-1331.
45. Tian, Q.; Zhang, J.; Tan, T.M.; Chan, E.; Duan, W.; Chan, S. Y.; Boelsterli, U. A.; Ho, P.C.; Yang, H.; Bian, J.S.; Chan, E.; Duan, W.; Chan, S.Y.; Boelsterli, U.A.; Ho, P.C.; Yang, H.; Bian, J.S.; Huang, M.; Zhu, Y.Z.; Xiong, W.; Li, X.; Zhou, S. Human multidrug resistance associated protein 4 confers resistance to camptothecins. Pharm. Res., 2005, 22, 1837-1853.
46. Reid, G.; Wielinga, P.; Zelcer, N.; van der Heijden, I.; Kuil, A.; de Haas, M.; Wijnholds, J.; Borst, P. The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc. Natl. Acad. Sci. USA, 2003, 100, 9244-9249.
47. Zelcer, N.; Reid, G.; Wielinga, P.; Kuil, A.; van der Heijden, I.; Schuetz, J.D.; Borst, P. Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATPbinding cassette C4). Biochem. J., 2003, 371, 361-367.
48. Denk, G. U.; Soroka, C.J.; Takeyama, Y.; Chen, W.S.; Schuetz, J.D.; Boyer, J.L. Multidrug resistance-associated protein 4 is upregulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. J. Hepatol., 2004, 40, 585-591.
49. Krishnamurthy, P.; Schwab, M.; Takenaka, K.; Nachagari, D.; Morgan, J.; Leslie, M.; Du, W.; Boyd, K.; Cheok, M.; Nakauchi, H.; Marzolini, C.; Kim, R.B.; Poonkuzhali, B.; Schuetz, E.; Evans, W.; Relling, M.; Schuetz, J.D. Transporter-mediated protection against thiopurine-induced hematopoietic toxicity. Cancer Res., 2008, 68, 4983-4989.
50. Ando, M.; Ando, Y.; Hasegawa, Y.; Sekido, Y.; Shimokata, K.; Horibe, K. Genetic polymorphisms of thiopurine Smethyltransferase and 6-mercaptopurine toxicity in Japanese children with acute lymphoblastic leukaemia. Pharmacogenetics, 2001, 11, 269-273.
51. Yabuuchi, H.; Shimizu, H.; Takayanagi, S.; Ishikawa, T. Multiple splicing variants of two new human ATP-binding cassette transporters, ABCC11 and ABCC12. Biochem. Biophys. Res. Commun., 2001, 288, 933-939.
52. Tammur, J.; Prades, C.; Arnould, I.; Rzhetsky, A.; Hutchinson, A.; Adachi, M.; Schuetz, J.D.; Swoboda, K.J.; Ptacek, L.J.; Rosier, M.; Dean, M.; Allikmets, R. Two new genes from the human ATPbinding cassette transporter superfamily, ABCC11 and ABCC12, tandemly duplicated on chromosome 16q12. Gene, 2001, 273, 89-96.
53. Bera, T.K.; Lee, S.; Salvatore, G.; Lee, B.; Pastan, I. MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer. Mol. Med., 2001, 7, 509-516.
54. Ono, N.; van der Heiden, I.; Schffer, G.L.; van de Wetering, K.; van Deenter, E. de Haas, M.; Boerke, A.; Gadella, B.M.; de Rooij, D.G.; Neefjes, J.J.; Groothuis, T.A.M.; Oomen, L.; Brocks, L.; Ishikawa, T.; Borst, P. Multidrug resistance-associated protein 9 (ABCC12) is present in mouse and boar sperm. Biochem. J., 2007, 406, 31-40.
55. Shimizu, H.; Taniguchi, H.; Hippo, Y.; Hayashizaki, Y.; Aburatani, H.; Ishikawa, T. Characterization of the mouse Abcc12 gene and its transcript encoding an ATP-binding cassette transporter, an orthologue of human ABCC12. Gene, 2003, 310, 17-28.
56. Kruh, G.D.; Guo, Y.; Hopper-Borge, E.; Belinsky, M.G.; Chen, Z.S. ABCC10, ABCC11, and ABCC12. Pflugers. Arch., 2007, 453, 675-684.
57. Bortfeld, M.; Rius, M.; Konig, J.; Herold-Mende, C.; Nies, A. T.; Keppler, D. Human multidrug resistance protein 8 (MRP8/ABCC11), an apical efflux pump for steroid sulfates, is an axonal protein of the CNS and peripheral nervous system. Neuroscience, 2006, 137, 1247-1257.
58. Chen, Z.S.; Guo, Y.; Belinsky, M.G.; Kotova, E.; Kruh, G.D. Transport of bile acids, sulfated steroids, estradiol 17-beta-Dglucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11). Mol. Pharmacol., 2005, 67, 545-557.
59. Guo, Y.; Kotova, E.; Chen, Z.S.; Lee, K.; Hopper-Borge, E.; Belinsky, M.G.; Kruh, G.D. MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'-(2'-phosphonylmethoxyethyl)adenine. J. Biol. Chem., 2003, 278, 29509-29514.
60. Yoshiura, K.; Kinoshita, A.; Ishida, T.; Ninokata, A.; Ishikawa, T.; Kaname, T.; Bannai, M.; Tokunaga, K.; Sonoda, S.; Komaki, R.; Ihara, M.; Saenko, V.A.; Alipov, G.K.; Sekine, I.; Komatsu, K.; Takahashi, H.; Nakashima, M.; Sosonkina, N.; Mapendano, C.K.; Ghadami, M.; Nomura, M.; Liang, D.S.; Miwa, N.; Kim, D.K.; Garidkhuu, A.; Natsume, N.; Ohta, T,.; Tomita, H.; Kaneko, A.; Kikuchi, M.; Russomando, G.; Hirayama, K.; Ishibashi, M.; Takahashi, A.; Saitou, N.; Murray, J.C.; Saito, S.; Nakamura, Y.; Nii kawa, N. A SNP in the ABCC11 gene is the determinant of human earwax type. Nat. Genet., 2006, 38, 324-330.
61. Toyoda, Y.; Hagiya, Y.; Adachi, T.; Hoshijima, K.; Kuo, M.T.; Ishikawa, T. MRP class of human ATP binding cassette (ABC) transporters: historical background and new research directions. Xenobiotica, 2008, 38, 833-862.
62. Yamaguchi-Kabata, Y.; Nakazono, K.; Takahashi, A.; Saito, S.; Hosono, N.; Kubo, M.; Nakamura, Y.; Kamatani, N. Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. Am. J. Hum. Genet., 2008, 83, 445-456.
63. Martin, M.; Saathoff, M.; Kuhn, F.; Max, H.; Terstegen, L.; Natsch, A. A functional ABCC11 allele is essential in the biochemical formation of human axillary odor. J. Invest. Dermatol., 2010, 130, 529-540.
64. Petrakis, N.L. Cerumen genetics and human breast cancer. Science, 1971, 173, 347-349.
65. Ing, R.; Petrakis, L.; Ho, H.C. Evidence against association between wet cerumen and breast cancer. Lancet, 1973, 1, 41.
66. Ota, I.; Sakurai, A.; Toyoda, Y.; Morita, S.; Sasaki, T.; Chishima, T.; Yamakado, M.; Kawai, Y.; Ishidao, T.; Lezhava, A.; Yoshiura, K.; Togo, S.; Hayashizaki, Y.; Ishikawa, T.; Ishikawa, T.; Endo, I.; Shimada, H. Association between breast cancer risk and the wildtype allele of human ABC transporter ABCC11. Anticancer Res., 2010, 30(12), 5189-5194.
67. Honorat, M.; Mesnier, A.; Vendrell, J.; Guitton, J.; Bieche, I.; Lidereau, R.; Kruh, G.D.; Dumontet, C.; Cohen, P.; Payen, L. ABCC11 expression is regulated by estrogen in MCF7 cells, correlated with estrogen receptor wwwexpression in postmenopausal breast tumors and overexpression in tamoxifen-resistant breast cancer cells. Endocr.-Relat. Cancer, 2008, 15, 125-138.
68. Lezhava, A.; Ishidao, T.; Ishizu, Y.; Naito, K.; Hanami, T.; Katayama, A.; Kogo, Y.; Soma, T.; Ikeda, S.; Murakami, K.; Nogawa, C.; Itoh, M.; Mitani, Y.; Harbers, M.; Okamoto, A.; Hayashizaki, Y. Exciton Primer-mediated SNP detection in SmartAmp2 reactions. Hum. Mutat., 2010, 31(2), 208-217.